Methods |
RCT comparing inogatran versus heparin in unstable coronary disease. |
Data |
1209 patients were randomised (904/305, respectively in each treatment group). |
Comparisons |
Onsite assessment (local investigator blinded) versus assessment by an AC (blinding status not reported). |
Outcomes |
The outcome selected was death, myocardial infarction (reinfarction), refractory angina or recurrent angina.The study's primary outcome was a composite of these events at 7 days. |
Notes |
|
Risk of bias |
Item |
Authors' judgement |
Description |
Method for selecting cases to adjudicate? |
No |
All suspect events adjudicated were identified by onsite assessor who was blinded to allocated treatment. |